A subscription to JoVE is required to view this content. Sign in or start your free trial.
We present a protocol to generate a minimally invasive orthotopic pancreatic cancer model by ultrasound-guided injection of human pancreatic cancer cells and the subsequent monitoring of tumor growth in vivo by ultrasound imaging.
Pancreatic cancer (PCa) represents one of the deadliest cancer types worldwide. The reasons for PCa malignancy mainly rely on its intrinsic malignant behavior and high resistance to therapeutic treatments. Indeed, despite many efforts, both standard chemotherapy and innovative target therapies have substantially failed when moved from preclinical evaluation to the clinical setting. In this scenario, the development of preclinical mouse models better mimicking in vivo characteristics of PCa is urgently needed to test newly developed drugs. The present protocol describes a method to generate a mouse model of PCa, represented by an orthotopic xenograft obtained by ultrasound-guided injection of human pancreatic tumor cells. Using such a reliable and minimally invasive protocol, we also provide evidence of in vivo engraftment and development of tumor masses, which can be monitored by ultrasound (US) imaging. A noteworthy aspect of the PCa model described here is the slow development of the tumor masses over time, which allows precise identification of the starting point for pharmacological treatments and better monitoring of the effects of therapeutic interventions. Moreover, the technique described here is an example of implementation of the 3Rs principles since it minimizes pain and suffering and directly improves the welfare of animals in research.
PCa, and its most common form, the Pancreatic Ductal Adeno Carcinoma (PDAC), is one of the most common causes of cancer-related death with a 1-year survival rate lower than 20% and a 5-year survival rate of 8%, regardless of the stage1,2. The disease is almost always fatal, and its incidence is forecasted to continuously grow in the next years, unlike other cancer types, whose incidence is declining3. Factors such as late cancer detection, the tendency of rapid progression, and lack of specific therapies lead to a poor prognosis of PCa4. Great advances in cancer ....
The present protocol received approval from the Italian Ministry of Health with the authorization number 843/2020-PR. In order to ensure aseptic conditions, the animals were maintained inside the barrier room of the research animal vivarium (Ce.S.A.L.) of the University of Florence. All procedures were performed in the same space where the mice were housed at the LIGeMA facility of the University of Florence (Italy).
1. Cell preparation
Following the protocol described above, mice were first anesthetized in an isoflurane chamber, and placed on the animal platform (Figure 1A). The pancreas was visualized with ultrasound imaging (Figure 1B). A 50 µL Hamilton syringe was loaded with 1 x 106 PANC1 cells suspended in 20 µL of PBS and placed on the needle holder (Figure 1C). The optimal angle between the syringe and the US transducer was 45° (
Although the use of US imaging is widespread in the clinic, tumor development in many preclinical mouse models is usually described using bioluminescent imaging11. The latter is an indirect way to evaluate tumor engraftment and expansion and it also does not provide a reliable tumor growth kinetics. In the present study, we have applied US imaging for performing cell injection as well as for monitoring tumor development. The protocol we have described and the results we have provided represent a r.......
This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, grant no. 15627, IG 21510, and IG 19766) to AA, PRIN Italian Ministry of University and Research (MIUR). Leveraging basic knowledge of ion channel network in cancer for innovative therapeutic strategies (LIONESS) 20174TB8KW to AA, pHioniC: European Union's Horizon 2020 grant No 813834 to AA. CD was supported by a AIRC fellowship for Italy ID 24020.
....Name | Company | Catalog Number | Comments |
100 mm Petri dish | Sarstedt, Germany | P5856 | |
3D-Mode package | Visualsonics Fujifilm, Italy | Includes the 3D Motor; necessary for volumetric imaging | |
Aquasonic 100, Sonypack 5 lt Ultrasound Transmission Gel | PARKER LABORATORIES, INC. | 150 | Gel for ultrasound |
Athymic Mice (Nude-Foxn1nu) | ENVIGO, Italy | 69 | 20 females, 8 weeks old, Athymic Nude-Foxn1nu, 20-22 g body weight |
CO2 Incubator Function Line | Heraeus Instruments, Germany | BB16-ICN2 | |
Display of ECG, Respiration Waveform and body temperature | Visualsonics Fujifilm, Italy | 11426 | |
DMEM (Dulbecco’s Modified Eagle Medium) | Euroclone Spa, Italy | ECM0101L | |
DPBS (Dulbecco’s Phosphate Buffered Saline) | Euroclone Spa, Italy | ECB4004L | |
Eppendorf (1.5mL) | Sarstedt, Germany | 72.690.001 | |
FBS (Fetal Bovine Serum) | Euroclone Spa, Italy | ECS0170L | |
Hamilton Needle Pointstyle 4, lenght 30 mm, 28 Gauge | Permax S.r.l., Italy | 7803-02 | |
Hamilton Syringe 705RM 50 µL | Permax S.r.l., Italy | 7637-01 | |
Isoflo (250 mL) | Ecuphar | 7081219 | |
L-glutamine 100X | Euroclone Spa, Italy | ECB3000D | |
Mouse Handling table II | Visualsonics Fujifilm, Italy | 50249 | |
MX550D: 55 MHz MX Series Transducer | Visualsonics Fujifilm, Italy | 51069 | Ultrasound Transducers |
Oxygen/isofluorane mixer | Angelo Franceschini S.r.l. | LFY-I-5A | |
PANC1 cell line | American Type Culture Collection (ATCC), USA | CRL-1469 | |
Rimadyl (carprofen) | Pfizer | 11319 | 20 mL, injection solution |
Trypsin-EDTA 1X in PBS | Euroclone Spa, Italy | ECB3052D | |
Vet ointment for eyes, Systane nighttime | Alcon | 509/28555-1 | |
Vevo Compact Dual Anesthesia System (Tabletop Version) | Visualsonics Fujifilm, Italy | VS-12055 | complete with gas chamber |
Vevo Imaging Station 2 | Visualsonics Fujifilm, Italy | VS-11983 | Imaging WorkStation 1 plus Imaging Station Extension with injection mount |
Vevo Lab | Visualsonics Fujifilm, Italy | VS-20034 | Data Analysis Software |
Vevo LAZR-X Photoacoustic Imaging System | Visualsonics Fujifilm, Italy | VS-20054 | Includes analytic software package for B-mode |
Vevo Photoacoustic Enclosure | Visualsonics Fujifilm, Italy | 53157 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved